research The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.
Search
forResearch
5 / 163 results
research Hormonal contraceptives: pharmacology tailored to women's health
This review discusses developments in oral contraceptives, highlighting improved individualization, reduced side effects, and enhanced suitability for various women's health needs, but it reports no new clinical results.
research Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
This study concluded that combined hormonal contraceptives containing desogestrel, drospirenone, or cyproterone acetate were associated with a higher risk of venous thromboembolism compared to those containing levonorgestrel.
research Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
This systematic review suggests that current evidence does not support routinely discontinuing gender-affirming hormone treatments before surgery, especially testosterone and spironolactone, due to limited data on related perioperative risks.
research Gender-Affirming Hormone Therapy for Transgender Females
This article states that hormone therapy with estrogens and antiandrogens for transgender females is within an obstetrician-gynecologist's practice scope and involves careful dosing and monitoring to manage short-term thrombotic risks.
Learn
— no results
Community Join
— no results
Experts
— no results
Clinics
— no results